Efficient Drug Development
TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.
Our latest developments
23 resultaten, getoond 6 t/m 10
Spatial Mass Spectrometry
Mass spectrometry imaging (MSI) provides tissue-level evidence of drug distribution, mechanism of action and molecular effects, supporting early drug development and disease research.
Atherosclerosis
A preclinical model that captures the full complexity of CKM syndrome
From lab to life in 24 Hours: i-screen demonstrates correlation between laboratory and human gut responses
Testing medicines outside the body: intestinal–liver–kidney model accelerates drug development
Contact us
-
Steven Erpelinck
Functie:Principal Business Developer-
Standplaats:Leiden - Sylviusweg
-
Email:Email Steven
-
LinkedIn:Steven on LinkedIn
-
-
Martin Kirch
Functie:Director Health-
Standplaats:Leiden - Sylviusweg
-
Email:Email Martin
-